Senior insider sale
CMO at LONGBOARD PHARMACEUTICALS, INC. — senior position signals high conviction
$584.8K
16.67K shares
What this filing means
KAYE RANDALL plans to sell 16.67K shares of LONGBOARD PHARMACEUTICALS, INC. valued at approximately $584.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2024ACC: 0001950047-24-005927
Officer· CMO
Since Mar 2022
16.67K
Shares to sell
$584.8K
Approx. market value
16.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/12/2024
16.67KTotal acquired16.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2024 | Exercise of Stock Options Cash | 16.67K | — |
| Total | 16.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.67K
Market value
$584.8K
8/12/2024
Total
Units
16.67K
Value
$584.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2024 | 16.67K | $584.8K | NASDAQ | Planned |
| Total | 16.67K | $584.8K | ||